Cardiac function in 7-8-year-old offspring of women with type 1 diabetes

Maarten Rijpert1, Johannes M P J Breur, Inge M Evers

  • 1Department of Pediatrics, Wilhelmina Children's Hospital, University Medical Center Utrecht, P.O. Box 85090, 3508 AB Utrecht, The Netherlands. m.rijpert@umcutrecht.nl

Insights

Children born to mothers with type 1 diabetes show reassuring cardiac function at 7-8 years old. Neonatal size and maternal glucose control did not negatively impact their heart health.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pediatrics

Background:

  • Offspring of type 1 diabetic mothers (ODMs) face risks for neonatal macrosomia and later cardiovascular issues.
  • Cardiac outcomes in ODMs have not been previously studied.
  • Understanding long-term cardiac health in ODMs is crucial for preventative care.

Purpose of the Study:

  • To investigate cardiac dimensions and function in 7-8-year-old ODMs.
  • To assess the relationship between neonatal macrosomia, maternal glycemic control, and cardiac outcomes in ODMs.
  • To compare cardiac parameters in ODMs with a control group of children from nondiabetic mothers.

Main Methods:

  • Cardiac assessment of 30 ODMs and 30 controls aged 7-8 years.
  • Evaluation of cardiac dimensions, systolic, and diastolic function.
  • Analysis correlating cardiac outcomes with neonatal birth weight and maternal glycemic control during pregnancy.

Main Results:

  • Cardiac dimensions and function (systolic and diastolic) were comparable between ODMs and controls.
  • Neonatal macrosomia was not associated with adverse cardiac outcomes in ODMs.
  • Poorer maternal glycemic control during pregnancy did not correlate with worse cardiac function in ODMs.

Conclusions:

  • Cardiac function in 7-8-year-old ODMs is reassuring and similar to controls.
  • Early life factors like macrosomia and maternal glucose control do not appear to negatively impact cardiac health at this age.
  • This study provides valuable insights into the long-term cardiac well-being of children born to mothers with type 1 diabetes.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...